Close
Help





JOURNAL

Clinical Medicine Insights: Case Reports

326,127 Journal Article Views | Journal Analytics

Treatment with Etanercept in a Patient with Rheumatoid Arthritis-Associated Interstitial Lung Disease

Submit a Paper



Publication Date: 06 Oct 2011

Type: Case report

Journal: Clinical Medicine Insights: Case Reports

Citation: Clinical Medicine Insights: Case Reports 2011:4 49-52

doi: 10.4137/CCRep.S8150

Abstract

We report a case of a 52-year-old woman with a 1-year history of rheumatoid arthritis-associated interstitial lung disease referred to hospital because of aggravated pulmonary symptoms in spite of intensive treatment including prednisone, azathioprine and triptergium glycoside. We subsequently initiated treatment with 25 mg of etanercept, subcutaneously injected twice weekly. Following 6 months of therapy with this agent, sustained improvement in dyspnea, cough was reported by the patient and respiratory function test showed marked improvement. The improvement was confirmed by reduced middle and lower lung markings on chest radiography and high-resolution CT scan. This report suggests etanercept may be effective in the treatment of rheumatoid arthritis-associated interstitial lung disease.


Downloads

PDF  (464.11 KB PDF FORMAT)

RIS citation   (ENDNOTE, REFERENCE MANAGER, PROCITE, REFWORKS)

BibTex citation   (BIBDESK, LATEX)

XML






What Your Colleagues Say About Clinical Medicine Insights: Case Reports
This is my first publication with Libertas Academica. The whole process from submission to publication and responses were extremely rapid. The editorial staff informed me of the progress of the submission step by step. Thank you for your great service and kindness.
Dr Kazuyuki Karasuyama (Department of Orthopaedic Surgery, Kyushu University, Fukuoka, Japan)
More Testimonials

Quick Links


New article and journal news notification services